Holen Sie sich die Stockscreener-App
1.055
3.43%
0.035
Schlusskurs vom Vortag:
$1.02
Offen:
$1.015
24-Stunden-Volumen:
1.10M
Relative Volume:
0.95
Marktkapitalisierung:
$145.26M
Einnahmen:
$4.35M
Nettoeinkommen (Verlust:
$-45.53M
KGV:
-0.9769
EPS:
-1.08
Netto-Cashflow:
$-44.79M
1W Leistung:
-1.40%
1M Leistung:
-12.81%
6M Leistung:
-20.68%
1J Leistung:
+5.61%
1-Tages-Spanne:
$1.00
$1.07
1-Wochen-Bereich:
$1.00
$1.10
52-Wochen-Spanne:
$0.7501
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Firmenname
Lucid Diagnostics Inc
Sektor
Branche
Telefon
212 949 4319
Adresse
360 MADISON AVENUE, NEW YORK
Vergleichen Sie LUCD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.055 | 133.72M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2021-11-08 | Eingeleitet | BTIG Research | Buy |
| 2021-11-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-11-08 | Eingeleitet | Needham | Buy |
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
GenomeWeb Names Lucid Diagnostics (Nasdaq: LUCD) 2025 Best Places to Work Honoree - Stock Titan
Ranking Lucid Diagnostics Inc. among high performing stocks via tools2025 Top Decliners & AI Powered Trade Plan Recommendations - newser.com
Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Canada
Developing predictive dashboards with Lucid Diagnostics Inc. dataBear Alert & Fast Gain Swing Alerts - newser.com
Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald - Investing.com
Live market analysis of Lucid Diagnostics Inc.Weekly Market Report & Long Hold Capital Preservation Tips - newser.com
Why retail investors favor Lucid Diagnostics Inc. stockAnalyst Downgrade & Stock Portfolio Risk Control - newser.com
Is Lucid Diagnostics Inc. stock oversold or undervaluedMarket Growth Report & Pattern Based Trade Signal System - newser.com
Measuring Lucid Diagnostics Inc.’s beta against major indices - newser.com
Lucid Diagnostics’ Earnings Call: Strategic Wins Amid Challenges - MSN
Combining machine learning predictions for Lucid Diagnostics Inc.2025 Major Catalysts & Daily Volume Surge Trade Alerts - newser.com
Why Lucid Diagnostics Inc. stock is considered a top pickJuly 2025 Momentum & Community Consensus Picks - newser.com
Is Lucid Diagnostics Inc. meeting your algorithmic filter criteriaEarnings Performance Report & Weekly Momentum Stock Picks - newser.com
Earnings call transcript: Lucid Diagnostics Q3 2025 reports revenue growth and strategic advancements - Investing.com Nigeria
Lucid Diagnostics Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:LUCD) 2025-11-14 - Seeking Alpha
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Eastern Progress
Lucid Diagnostics Inc. (LUCD) Reports Q3 Loss, Lags Revenue Estimates - MSN
Lucid Diagnostics Gains Medicare Support for EsoGuard - MSN
Is Lucid Diagnostics Inc. stock ready for a breakoutJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com
PAVmed Inc (PAVM) Q3 2025 Earnings Call Highlights: Strategic Pa - GuruFocus
PAVmed Inc (PAVM) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial ... - Yahoo Finance
Lucid Diagnostics to Participate in the Canaccord Genuity MedTec - GuruFocus
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2025 Earnings Call Transcript - Insider Monkey
Earnings Call Summary | Lucid Diagnostics(LUCD.US) Q3 2025 Earnings Conference - 富途牛牛
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results - MarketScreener
Needham reiterates Buy rating on Lucid Diagnostics stock amid EsoGuard growth - Investing.com Nigeria
Needham Reiterates Lucid Diagnostics (LUCD) Buy Recommendation - Nasdaq
Lucid Diagnostics earnings beat, revenue fell short of estimates By Investing.com - Investing.com Australia
Lucid Diagnostics Inc (LUCD) Q3 2025 Earnings Call Highlights: Strategic Growth Plans Amidst ... By GuruFocus - Investing.com Canada
Lucid Diagnostics Reports Q3 2025 Financial Results - TipRanks
Lucid Diagnostics Q3 2025 Earnings Call Transcript - MarketBeat
Finanzdaten der Lucid Diagnostics Inc-Aktie (LUCD)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):